3,5-dihydroxyphenylglycine has been researched along with sirolimus in 3 studies
| Studies (3,5-dihydroxyphenylglycine) | Trials (3,5-dihydroxyphenylglycine) | Recent Studies (post-2010) (3,5-dihydroxyphenylglycine) | Studies (sirolimus) | Trials (sirolimus) | Recent Studies (post-2010) (sirolimus) |
|---|---|---|---|---|---|
| 301 | 1 | 61 | 20,711 | 2,368 | 11,516 |
| Protein | Taxonomy | 3,5-dihydroxyphenylglycine (IC50) | sirolimus (IC50) |
|---|---|---|---|
| Bile salt export pump | Homo sapiens (human) | 10 | |
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | 1.25 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 2 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 2 | |
| Peptidyl-prolyl cis-trans isomerase FKBP1A | Mus musculus (house mouse) | 0.001 | |
| Cytochrome P450 2C19 | Homo sapiens (human) | 4 | |
| Serine/threonine-protein kinase mTOR | Homo sapiens (human) | 0.0897 | |
| Peptidyl-prolyl cis-trans isomerase FKBP1A | Homo sapiens (human) | 0.0042 | |
| Regulatory-associated protein of mTOR | Homo sapiens (human) | 0.225 | |
| Target of rapamycin complex subunit LST8 | Homo sapiens (human) | 0.225 | |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | Homo sapiens (human) | 1.9 | |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 1.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hsu, KS; Huang, CC; You, JL; Zho, WM | 1 |
| Hou, L; Klann, E | 1 |
| Bennett, MV; Francesconi, A; Kumari, R; Takayasu, Y; Takeuchi, K; Zukin, RS | 1 |
3 other study(ies) available for 3,5-dihydroxyphenylglycine and sirolimus
| Article | Year |
|---|---|
The group I metabotropic glutamate receptor agonist (S)-3,5-dihydroxyphenylglycine induces a novel form of depotentiation in the CA1 region of the hippocampus.
Topics: Animals; Anti-Bacterial Agents; Excitatory Amino Acid Agonists; Excitatory Postsynaptic Potentials; Glycine; Hippocampus; In Vitro Techniques; Long-Term Potentiation; Male; Neural Inhibition; Rats; Rats, Sprague-Dawley; Receptor, Metabotropic Glutamate 5; Receptors, AMPA; Receptors, Metabotropic Glutamate; Resorcinols; Sirolimus; Synaptic Transmission | 2002 |
Activation of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin signaling pathway is required for metabotropic glutamate receptor-dependent long-term depression.
Topics: 3-Phosphoinositide-Dependent Protein Kinases; Androstadienes; Animals; Benzoates; Chromones; Dendrites; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Glycine; Hippocampus; Long-Term Synaptic Depression; Male; Mice; Mice, Inbred C57BL; Morpholines; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Kinases; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Pyramidal Cells; Pyridines; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Resorcinols; Signal Transduction; Sirolimus; Synaptosomes; Tacrolimus; TOR Serine-Threonine Kinases; Wortmannin | 2004 |
Caveolin-1 knockout mice exhibit impaired induction of mGluR-dependent long-term depression at CA3-CA1 synapses.
Topics: Animals; Antibiotics, Antineoplastic; Butadienes; Caveolin 1; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Extracellular Signal-Regulated MAP Kinases; Glycine; Hippocampus; Long-Term Synaptic Depression; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitriles; Patch-Clamp Techniques; Receptors, Metabotropic Glutamate; Resorcinols; Signal Transduction; Sirolimus; Synapses; TOR Serine-Threonine Kinases | 2010 |